Ipilimumab-related hypophysitis may precede severe CNS immune attack

Ann Oncol. 2016 Oct;27(10):1975-6. doi: 10.1093/annonc/mdw255. Epub 2016 Jun 29.

Authors

T Köessler¹, T Olivier², S Fertani², E Marinari³, V Dutoit³, P-Y Dietrich³

Affiliations

¹ Center of Oncology thibaud.kossler@hcuge.ch.
² Center of Oncology.
³ Center of Oncology Laboratory of Tumor Immunology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.

PMID: 27358386
DOI: 10.1093/annonc/mdw255

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Female
Humans
Hypophysitis / chemically induced*
Hypophysitis / diagnosis
Hypophysitis / immunology*
Ipilimumab / adverse effects*
Middle Aged
Severity of Illness Index*

Substances

Antineoplastic Agents, Immunological
Ipilimumab